Wang Liwen, Yue Zhiwei, Guo Mengzheng, Fang Lianying, Bai Liang, Li Xinyu, Tao Yongqing, Wang Suying, Liu Qiang, Zhi Dexian, Zhao Hui
Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Department of Hematology and Tangshan Key Laboratory, Translational Medical Center, North China University of Science and Technology, Tangshan, Hebei 063000, China.
Biomed Res Int. 2016;2016:1068528. doi: 10.1155/2016/1068528. Epub 2016 Mar 27.
Hyperoside, an active compound found in plants of the genera Hypericum and Crataegus, is reported to exhibit antioxidant, anticancer, and anti-inflammatory activities. Induction of hepatic stellate cell (HSC) apoptosis is recognized as a promising strategy for attenuation of hepatic fibrosis. In this study, we investigated whether hyperoside treatment can exert antifibrotic effects in human LX-2 hepatic stellate cells. We found that hyperoside induced apoptosis in LX-2 cells and decreased levels of α-smooth muscle actin (α-SMA), type I collagen, and intracellular reactive oxygen species (ROS). Remarkably, hyperoside also inhibited the DNA-binding activity of the transcription factor NF-κB and altered expression levels of NF-κB-regulated genes related to apoptosis, including proapoptotic genes Bcl-Xs, DR4, Fas, and FasL and anti-apoptotic genes A20, c-IAP1, Bcl-X L , and RIP1. Our results suggest that hyperoside may have potential as a therapeutic agent for the treatment of liver fibrosis.
金丝桃苷是一种在金丝桃属和山楂属植物中发现的活性化合物,据报道具有抗氧化、抗癌和抗炎活性。诱导肝星状细胞(HSC)凋亡被认为是减轻肝纤维化的一种有前景的策略。在本研究中,我们调查了金丝桃苷处理是否能在人LX-2肝星状细胞中发挥抗纤维化作用。我们发现金丝桃苷诱导LX-2细胞凋亡,并降低α-平滑肌肌动蛋白(α-SMA)、I型胶原蛋白和细胞内活性氧(ROS)的水平。值得注意的是,金丝桃苷还抑制转录因子NF-κB的DNA结合活性,并改变与凋亡相关的NF-κB调节基因的表达水平,包括促凋亡基因Bcl-Xs、DR4、Fas和FasL以及抗凋亡基因A20、c-IAP1、Bcl-XL和RIP1。我们的结果表明,金丝桃苷可能具有作为治疗肝纤维化药物的潜力。